• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右肝切除术后残肝体积小于 30%的活体供者的选择和结果。

Selection and outcomes of living donors with a remnant volume less than 30% after right hepatectomy.

机构信息

National Cancer Center, Gyeonggi-Do, Republic of Korea.

出版信息

Liver Transpl. 2013 Aug;19(8):872-8. doi: 10.1002/lt.23677.

DOI:10.1002/lt.23677
PMID:23695974
Abstract

The evidence for defining a safe minimal remnant volume after living donor hepatectomy is insufficient. The aim of this study was to evaluate the outcomes of living donors with a remnant/total volume ratio (RTVR) < 30% after right hepatectomy according to the following selection criteria: the preservation of the middle hepatic vein (MHV), an age < 50 years, and no or mild fatty changes in healthy adults. All living donors who underwent right hepatectomy preserving the MHV at our institution between January 2005 and September 2011 were divided into 2 groups: group A with an RTVR < 30% and group B with an RTVR ≥ 30%. Perioperative data, complications by the Clavien classification, and outcomes with at least 15.1 months' follow-up were compared. Twenty-eight donors were enrolled in group A, and 260 were enrolled in group B. The estimated liver volume was strongly correlated with the actual graft weight (R(2)  = 0.608, P < 0.001). The calculated donation liver volume and the RTVR were significantly different between the 2 groups (P = 0.03 and P < 0.001, respectively). The peak postoperative aspartate aminotransferase levels, alanine aminotransferase levels, and international normalized ratios did not differ between the 2 groups. The peak total bilirubin level was higher for group A versus group B (P = 0.04). The hospital stay was longer for group A versus group B (P < 0.001). All donors recovered completely, and there were no significant differences in overall complications between the 2 groups. In conclusion, right hepatectomy preserving the MHV with an RTVR < 30% can be safely indicated for carefully selected living donors less than 50 years old with no or mild fatty changes.

摘要

右半肝切除术后保留肝中静脉,选择残余肝体积与全肝体积比(RTVR)<30%且年龄<50 岁、无或轻度脂肪肝的供体行肝切除术的安全性证据尚不充分。本研究旨在评估符合以下选择标准的右半肝切除术后保留肝中静脉的供体的结局:年龄<50 岁、无或轻度脂肪肝的健康成年人,其 RTVR<30%(A 组)和 RTVR≥30%(B 组)。2005 年 1 月至 2011 年 9 月,本机构对 28 例接受右半肝切除术后保留肝中静脉的供体进行分组,其中 A 组 28 例,B 组 260 例。比较了围手术期数据、Clavien 分级的并发症和至少 15.1 个月的随访结果。估计肝体积与实际移植肝重量呈强相关(R(2)=0.608,P<0.001)。两组间计算的供肝体积和 RTVR 差异有统计学意义(P=0.03 和 P<0.001)。两组间术后天门冬氨酸转氨酶、丙氨酸转氨酶峰值和国际标准化比值差异无统计学意义。A 组总胆红素峰值高于 B 组(P=0.04)。A 组的住院时间长于 B 组(P<0.001)。所有供者均完全恢复,两组间总体并发症无显著差异。总之,对于精心选择的、年龄<50 岁、无或轻度脂肪肝的供体,行保留肝中静脉的右半肝切除术且 RTVR<30%是安全的。

相似文献

1
Selection and outcomes of living donors with a remnant volume less than 30% after right hepatectomy.右肝切除术后残肝体积小于 30%的活体供者的选择和结果。
Liver Transpl. 2013 Aug;19(8):872-8. doi: 10.1002/lt.23677.
2
Right lobe living donors ages 55 years old and older in liver transplantation.肝移植中 55 岁及以上右叶活体供者。
Liver Transpl. 2017 Oct;23(10):1305-1311. doi: 10.1002/lt.24823.
3
Utilization of elderly donors in living donor liver transplantation: when more is less?老年供者在活体肝移植中的应用:多即是少?
Liver Transpl. 2011 May;17(5):548-55. doi: 10.1002/lt.22276.
4
Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy.右肝切除术后残余肝体积小于35%的供体的结局。
Liver Transpl. 2006 Feb;12(2):201-6. doi: 10.1002/lt.20592.
5
Effect of Middle Hepatic Vein Tributaries Preserving Technique Until Just Before Graft Retrieval on Donors' Surgical Outcomes in Living Donor Liver Transplantation.在活体肝移植中,直至供肝获取前保留肝中静脉分支技术对供体手术结局的影响。
Transplant Proc. 2018 Nov;50(9):2636-2639. doi: 10.1016/j.transproceed.2018.03.092. Epub 2018 Mar 19.
6
Harvesting the middle hepatic vein with a right hepatectomy does not increase the risk for the donor.在右半肝切除术中获取肝中静脉不会增加供体的风险。
Liver Transpl. 2004 Jan;10(1):71-6. doi: 10.1002/lt.20015.
7
Donor safety and remnant liver volume in living donor liver transplantation.活体肝移植中的供体安全性与残余肝体积
Liver Transpl. 2008 Aug;14(8):1174-9. doi: 10.1002/lt.21562.
8
Remnant liver regeneration and spleen volume changes after living liver donation: influence of the middle hepatic vein.活体肝移植术后残余肝再生及脾脏体积变化:肝中静脉的影响
Clin Transplant. 2006 Nov-Dec;20(6):725-31. doi: 10.1111/j.1399-0012.2006.00554.x.
9
Small remnant liver volume after right lobe living donor hepatectomy.右叶活体供肝肝切除术后小残余肝体积
Surgery. 2006 Nov;140(5):749-55. doi: 10.1016/j.surg.2006.02.019. Epub 2006 Aug 7.
10
Influence of outflow-obstructed liver volume and venous communication development: A three-dimensional volume study in living donors.流出道阻塞性肝体积和静脉连通发育的影响:活体供者的三维体积研究。
Liver Transpl. 2017 Dec;23(12):1531-1540. doi: 10.1002/lt.24849. Epub 2017 Nov 8.

引用本文的文献

1
Minimal Surgical Manpower for Living Donor Liver Transplantation.活体肝移植所需的最低手术人力
J Clin Med. 2022 Jul 24;11(15):4292. doi: 10.3390/jcm11154292.
2
Survival Analysis after Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single Center Cohort Study.肝细胞癌活体肝移植后的生存分析:一项单中心队列研究
Biology (Basel). 2021 May 20;10(5):446. doi: 10.3390/biology10050446.
3
Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy.右半肝活体肝移植术后残余肝体积和肝脂肪变性的临床结局
Ann Transplant. 2020 Mar 10;25:e919502. doi: 10.12659/AOT.919502.
4
Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation.ABO血型不相容对活体肝移植中肝动脉血栓形成的影响。
Ann Transl Med. 2019 Nov;7(22):625. doi: 10.21037/atm.2019.11.34.
5
Bilateral proficiency over time leads to reduced donor morbidity in living donor hepatectomy.随着时间推移,双侧熟练程度提高可降低活体肝移植供体的发病率。
Hepatobiliary Surg Nutr. 2019 Oct;8(5):459-469. doi: 10.21037/hbsn.2019.03.12.
6
Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.每日一次缓释他克莫司在活体肝移植中的安全性和有效性:一项开放标签、前瞻性、单臂、4期研究。
Ann Transplant. 2018 Oct 12;23:713-720. doi: 10.12659/AOT.910618.
7
Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.利用总肿瘤大小和(18)F-氟脱氧葡萄糖-正电子发射断层扫描/计算机断层扫描对肝细胞癌患者活体肝移植提出新的扩展选择标准:韩国国立癌症中心标准
World J Transplant. 2016 Jun 24;6(2):411-22. doi: 10.5500/wjt.v6.i2.411.
8
The Impact of a Surgical Protocol for Enhanced Recovery on Living Donor Right Hepatectomy: A Single-Center Cohort Study.强化康复外科方案对活体供体右半肝切除术的影响:一项单中心队列研究
Medicine (Baltimore). 2016 Apr;95(14):e3227. doi: 10.1097/MD.0000000000003227.
9
Pushing the frontiers of living donor right hepatectomy.拓展活体供体右半肝切除术的前沿领域。
World J Gastroenterol. 2014 Dec 28;20(48):18061-9. doi: 10.3748/wjg.v20.i48.18061.